With extensive expertise in the technology and healthcare sectors, the fund manager has successfully navigated various investment stages, primarily focusing on growth and late-stage opportunities. Active in both North America and Europe, they have overseen over 50 deals, demonstrating a robust track record of identifying high-potential companies. Their strategic approach blends data-driven analysis with an operator-first mindset, resulting in several notable exits that underscore their investment acumen. Through a thematic lens, they prioritize disruptive innovations that promise substantial market impact and long-term value creation.